LONDON, Dec. 08, 2025 (Korea Bizwire) – A sharp acceleration in global wealth migration in 2025 is colliding with rapidly diverging private healthcare costs worldwide, making the availability and costs of reliable private care a decisive factor in where high-net-worth families choose to live, invest, and secure residence or citizenship rights. New client data released [...]
DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time [...]
MANILA, Philippines, Dec. 08, 2025 (Korea Bizwire) – A damning analysis from the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), entitled “The FCTC Secretariat’s Deepening Legitimacy Problem”, exposes how the World Health Organization’s Framework Convention on Tobacco Control has been captured by American philanthropist-funded NGOs, fundamentally undermining the treaty’s credibility and harming global public health [...]
SPRING, Texas, Dec. 06, 2025 (Korea Bizwire) – Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today collaborative presentations at the 67th American Society of Hematology Annual Meeting and Exposition, in Orlando, Florida; with scientists from the Duke University School of Medicine in Durham, North Carolina; reporting data from preclinical studies [...]
Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment for R/M NPC, achieving mOS of 64.8 months and a 5-year OS rate of 52.3%. Torpalimab plus chemotherapy has been approved in over 40 countries, representing the new standard of care for the 1st line treatment [...]
SHANGHAI, Dec. 05, 2025 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug application (“NDA”) for the company’s product, roconkibart injection (a recombinant humanized anti-IL-17A monoclonal antibody injection, product code: [...]
WASHINGTON, Dec. 04, 2025 (Korea Bizwire) – The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia to support the country’s response to its first-ever outbreak of Marburg virus disease. Marburg is a highly contagious hemorrhagic fever disease and can have a high case fatality rate of [...]
The new global transparency tool will empower governments, researchers and civil society to monitor vessels involved in deep-sea mineral exploration Washington, D.C., United States, Dec. 04, 2025 (Korea Bizwire) – Global Fishing Watch, an international nonprofit organization advancing ocean governance through transparency of human activity at sea, and the Benioff Ocean Science Laboratory, at the University of [...]
AMSTERDAM, Dec. 04, 2025 (Korea Bizwire) – On one of the most popular dates for work festive parties, a new global study* from Heineken® 0.0, the World’s number 1† non-alcoholic beer, reveals that 2025 marks the first festive season where saying “no thanks” needs no excuse, with almost three-quarters (72%) of people confident to skip alcohol [...]
SAN FRANCISCO, Dec. 03, 2025 (Korea Bizwire) – Meltwater, a global leader in media, social, and influencer intelligence, has been recognized as a Leader in the new IDC MarketScape: Worldwide Influencer Management for SMB Companies 2025–2026 Vendor Assessment (doc #US52967425, November 2025). The recognition follows Meltwater’s recent recognition as a Leader in the IDC MarketScape: Worldwide Influencer Marketing Platforms [...]